ONCORUS INC (ONCR) Stock Fundamental Analysis

NASDAQ:ONCR • US68236R1032

0.1206 USD
-0.01 (-8.5%)
Last: Jun 20, 2023, 08:14 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

ONCR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 521 industry peers in the Biotechnology industry. While ONCR seems to be doing ok healthwise, there are quite some concerns on its profitability. ONCR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ONCR had negative earnings in the past year.
  • ONCR had a negative operating cash flow in the past year.
ONCR Yearly Net Income VS EBIT VS OCF VS FCFONCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 -20M -40M -60M -80M

1.2 Ratios

  • The profitability ratios for ONCR are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ONCR Yearly ROA, ROE, ROICONCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ONCR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ONCR Yearly Profit, Operating, Gross MarginsONCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • ONCR has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, ONCR has a worse debt to assets ratio.
ONCR Yearly Shares OutstandingONCR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
ONCR Yearly Total Debt VS Total AssetsONCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -5.89, we must say that ONCR is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -5.89, ONCR is doing worse than 68.01% of the companies in the same industry.
  • ONCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.89
ROIC/WACCN/A
WACCN/A
ONCR Yearly LT Debt VS Equity VS FCFONCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 50M -50M 100M

2.3 Liquidity

  • A Current Ratio of 1.50 indicates that ONCR should not have too much problems paying its short term obligations.
  • ONCR's Current ratio of 1.50 is on the low side compared to the rest of the industry. ONCR is outperformed by 81.67% of its industry peers.
  • A Quick Ratio of 1.50 indicates that ONCR should not have too much problems paying its short term obligations.
  • ONCR's Quick ratio of 1.50 is on the low side compared to the rest of the industry. ONCR is outperformed by 80.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.5
ONCR Yearly Current Assets VS Current LiabilitesONCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for ONCR have decreased strongly by -28.78% in the last year.
EPS 1Y (TTM)-28.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.01%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 21.17% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y34.04%
EPS Next 2Y30.28%
EPS Next 3Y21.17%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ONCR Yearly Revenue VS EstimatesONCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 10K 20K 30K 40K
ONCR Yearly EPS VS EstimatesONCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -1 -2 -3 -4 -5

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ONCR. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ONCR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ONCR Price Earnings VS Forward Price EarningsONCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ONCR Per share dataONCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ONCR's earnings are expected to grow with 21.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.28%
EPS Next 3Y21.17%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ONCR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ONCORUS INC

NASDAQ:ONCR (6/20/2023, 8:14:14 PM)

0.1206

-0.01 (-8.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)05-22
Earnings (Next)08-02
Inst Owners9.11%
Inst Owner Change0%
Ins Owners11.14%
Ins Owner Change0%
Market Cap3.15M
Revenue(TTM)N/A
Net Income(TTM)-90.54M
Analysts45.71
Price Target5.1 (4128.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.88%
Min EPS beat(2)-65.27%
Max EPS beat(2)-4.49%
EPS beat(4)1
Avg EPS beat(4)-17.24%
Min EPS beat(4)-65.27%
Max EPS beat(4)1.09%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)53.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.81%
EPS NY rev (1m)0%
EPS NY rev (3m)-21.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.1
P/tB 0.1
EV/EBITDA N/A
EPS(TTM)-3.49
EYN/A
EPS(NY)-0.91
Fwd EYN/A
FCF(TTM)-2.83
FCFYN/A
OCF(TTM)-2.13
OCFYN/A
SpS0
BVpS1.19
TBVpS1.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 437.27%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.5
Altman-Z -5.89
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)372.13%
Cap/Depr(5y)247.64%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.01%
EPS Next Y34.04%
EPS Next 2Y30.28%
EPS Next 3Y21.17%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.81%
OCF growth 3YN/A
OCF growth 5YN/A

ONCORUS INC / ONCR FAQ

What is the fundamental rating for ONCR stock?

ChartMill assigns a fundamental rating of 2 / 10 to ONCR.


What is the valuation status of ONCORUS INC (ONCR) stock?

ChartMill assigns a valuation rating of 3 / 10 to ONCORUS INC (ONCR). This can be considered as Overvalued.


Can you provide the profitability details for ONCORUS INC?

ONCORUS INC (ONCR) has a profitability rating of 1 / 10.


Can you provide the financial health for ONCR stock?

The financial health rating of ONCORUS INC (ONCR) is 2 / 10.